-
www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
January 01, 2024 - At least 25% of
patients with the highest-risk conditions (e.g.,
vasculitis) or highest-risk immunosuppressants
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-10-workflow-mapping.pdf
September 01, 2015 - processes for
specific patient groups:
• Preventive care
• Acute problems (major/minor)
• Chronic conditions
-
www.ahrq.gov/research/findings/final-reports/crctoolkit/crctoolkit3.html
April 01, 2018 - is affiliated with or finding evidence of prior colorectal cancer screening or other disqualifying conditions
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
November 29, 2004 - of these patients have other diseases;
if we had considered errors related to treatments for these conditions
-
www.ahrq.gov/news/events/nac/2020-07-nac/nacmtg071420-minutes.html
November 01, 2020 - on how responses to COVID-19 affect socially vulnerable populations and people with multiple chronic conditions
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Karsh.pdf
April 22, 2004 - electronic
medical records associated with improved perceptions
of the quality of medical records, working conditions
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Campbell-R_106.pdf
April 14, 2008 - range of potential patient harms that span adverse drug reactions, injuries, and other
serious medical conditions
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Hagg_80.pdf
January 01, 2007 - The digital camera is
used to record processing
conditions prior to and
following improvements.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Williams_115.pdf
June 19, 2008 - Such protocols are
generally considered highly effective in trauma, but they are much less useful in conditions
-
www.ahrq.gov/evidencenow/heart-health/cholesterol/uspstf.html
September 01, 2018 - Clinical Recommendation: Statins in Primary Prevention of CVD
Resource title: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication: The U.S. Preventive Services Task Force Recommendation
Resource description: This clinical recommendation summarizes the use of stat…
-
www.ahrq.gov/sites/default/files/publications/files/ptflowguide.pdf
January 01, 2014 - However, the potential for
these conditions to become life threatening while the patient waits to be
-
www.ahrq.gov/evidencenow/heart-health/cholesterol/primary-prevention.html
September 01, 2018 - Primary Prevention of Cardiovascular Events With Statins
Resource title: Primary Prevention of Cardiovascular Disease (CVD) Events with Statins
Resource description: This webinar slide deck and script reviews recommendations for lipid testing and CVD risk assessment, using assessment results and patient pre…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/carbapenem-resistant-1.pdf
March 01, 2020 - Other risk factors include intensive care unit
(ICU) stay, poor functional status, underlying medical
conditions … methods, supervised
adherence to the guidelines
via daily census reports on
carriers and their conditions
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/expanding-cardiac-rehab-implementation-guide.pdf
December 01, 2022 - .
• Reduced cost of hospitalizations for cardiac conditions
• Fewer payer penalties for excess cardiac … Patients with these conditions should remain
in FBCR and be evaluated by CR staff and their cases discussed
-
www.ahrq.gov/evidencenow/heart-health/cholesterol/statins.html
September 01, 2018 - Strategies to Better Manage Lipids—Statin Pearls
Resource title: Strategies to Better Manage Lipids—Statin Pearls
Resource description: This slide deck and transcript of a 20-minute video with a family physician at Virginia Commonwealth University reviews current recommendations for the use of statins in lo…
-
www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/hisph-slides-pt2.html
May 01, 2018 - Having these conditions in combination with diagnosed diabetes increases the likelihood of complications
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp1.pdf
January 01, 2009 - assessments provide organizations
with comprehensive, science-based information on common, costly medical conditions
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/presentations/2008update-full/slides.ppt
August 01, 2009 - follow-up for at least one month) was associated with a significantly higher quit rate compared to control conditions … Tobacco use treatments have been shown to be effective among smokers with a variety of comorbid medical conditions … The comorbid conditions and effective interventions include:
• Cardiovascular disease: psychosocial
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/pruprev/impguide.pdf
June 02, 2025 - On-Time Pressure Ulcer Prevention: Facilitator Training Instructor Guide—Implementation
AHRQ’s Safety Program for Nursing Homes: On-Time Pressure Ulcer Prevention 1
Implementation of
the Prevention
Reports
AHRQ’s Safety Program for Nursing
Homes: On-Time Pressure Ulcer
Prevention Facilitator Traini…
-
www.ahrq.gov/sites/default/files/2024-01/wessell2-report.pdf
January 01, 2024 - Final Progress Report: Reducing Adverse Drug Events From Anticoagulants, Diabetes Agents and Opioids in Primary Care
Final Progress Report
Reducing Adverse Drug Events from Anticoagulants, Diabetes Agents and Opioids in
Primary Care
Principal Investigator: Andrea M. Wessell, PharmD
Team Members: Steven M. Orns…